SCHEMBL5226840

SCHEMBL5226840

CCN(c1cccc(C)c1)S(=O)(=O)N(Cc1ccc(OCCc2nc(-c3ccc(C)cc3)oc2C)cc1)OC(C)=O

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 18/20 0.51
PPARG P37231 17/20 0.51
PPARD Q03181 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5229519 0.87 PPARG (0.50) PPARAPPARG
SCHEMBL5223715 0.87 PPARG (0.57) PPARAPPARG
SCHEMBL5231228 0.85 PPARA (0.49) PPARAPPARGPPARD
SCHEMBL5261705 0.85 PPARG (0.55) PPARAPPARGPPARD
SCHEMBL5228028 0.84 PPARG (0.48) PPARAPPARG
SCHEMBL5228797 0.83 PPARG (0.53) PPARAPPARGPPARD
SCHEMBL5225245 0.82 PPARA (0.59) PPARAPPARG
SCHEMBL5227055 0.80 PPARG (0.58) PPARAPPARGPPARD
SCHEMBL5312588 0.80 PPARG (0.56) PPARAPPARG
SCHEMBL5231167 0.77 PPARG (0.55) PPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778654-A1 SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME Crystalgenomics, Inc. (KR) 2007-05-02 EP claimed
WO-2006006832-A1 SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME CRYSTALGENOMICS, INC. (KR) 2006-01-19 WO claimed